Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05326854
Other study ID # ESKISEHIROU1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 30, 2021
Est. completion date July 31, 2022

Study information

Verified date June 2022
Source Eskisehir Osmangazi University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was planned to evaluate the effectiveness of the navigation-assisted care program based on the Swanson Theory of Care, which was developed for women who underwent medical termination as a result of a complication caused by maternal or fetal reasons.


Description:

H1: Navigation-assisted care program based on Swanson care theory reduces perinatal grief levels of women. H2: Navigation-assisted care program based on Swanson care theory reduces depression-anxiety-stress levels of women H3: Navigation-assisted care program based on Swanson care theory positively affects women's coping and adjustment levels. Independent variables: Sociodemographic characteristics such as age, marital status, educational status and the Navigation Assisted Care Program Based on Swanson Care Theory constitute the independent variables. Dependent variables: Scores from Perinatal Grief Scale, Depression, Anxiety and Stress Scale, Coping and Adaptation Process Scale, discharge time, labor pain constitute the dependent variables. Preparation of mobile application: After the formation of the training content, expert opinions and the completion of the ethics committee process, the construction phase of the mobile application started. The mobile application was named "Pregnancy Loss Support Program". In order for the patients in the intervention group to log in to the mobile application, a user name and password were defined, and the user names and passwords defined during the installation of the mobile application were reported to them by the researcher. Before starting the patient interviews with the mobile application, trials were made and updates were made regarding the deficiencies. Continuous support was provided to people through the Messaging section, which offers instant messaging so that participants' questions can be answered. The questionnaires applied during the study were made available to the participants in the Survey section. In the video section, videos that will provide technical support for mobile application installation and use have been added. A symptom diary section was created in order for the participants to indicate the changes that occurred in them, and the participants were provided to report their symptoms from this section. - After the patient is admitted to the service at the first interview, data collection forms will be applied to the women. Afterwards, information will be given about the mobile application and its use, and the mobile application will be downloaded to the women's phones. The mobile application will be activated after the discharge of the patient, and the woman will be able to access the mobile application at discharge. The mobile application will be installed on the patient's phone at the first meeting in the hospital, and the patient will be informed about its use. - In the second meeting, before the termination, the Medical Post-Termination Training and Supportive Care Program will continue. - After the termination at the third meeting, the Medical Post-Termination Training and Supportive Care Program will continue. Telephone interviews and follow-up plans will be made with the patient after discharge. After the medical termination decision is taken, it is thought that there may be deficiencies during the training due to the high anxiety and stress levels of women, and the training program will be integrated into the mobile application so that women can access it at any time. In case of a problem with the use of the mobile application, women will be able to reach the researcher by phone during working hours and support will be provided by the researcher. In the study, it was planned to make home visits, but the follow-ups arising from the Coronavirus Pandemic process will be made in the form of telephone follow-up and follow-up. Survey and measurement tools will be applied.(Perinatal Grief Scale, Depression, Anxiety and Stress Scale, Coping and Adaptation Process Scale) - After the discharge, the fourth interview will take place in the first week, the problems experienced by the patient will be discussed and his questions will be answered. Post-Medical Termination Education and Supportive Care Program will continue. - After discharge, the fifth interview will be held in the second week and the problems experienced by the patient will be discussed. - After discharge, the sixth interview will be held in the fourth week and the problems experienced by the patient will be discussed. - The seventh interview will be held in the sixth week after discharge, during which the problems experienced by the patient will be discussed, data collection forms and measurement tools will be applied. (Perinatal Grief Scale, Depression, Anxiety and Stress Scale, Coping and Adaptation Process Scale) - The eighth interview will be held in the tenth week, during which the problems experienced by the patient will be discussed, data collection forms and measurement tools will be applied. (Perinatal Grief Scale, Depression, Anxiety and Stress Scale, Coping and Adaptation Process Scale) Applications to the control group In the control group, data collection forms and measurement tools will be applied after admission to the service. No application will be made other than the routine maintenance of the hospital. The routine care of the hospital applied to the control group within the scope of the research includes the information that should be given before, during and after the procedure that should be done depending on the medical intervention. In addition, there is no support program planned in the hospital and at discharge, and there is no follow-up after discharge. In studies evaluating the effectiveness of education in the literature, 6-8 weeks are considered appropriate for evaluation. For this reason, the first measurement will be made in the 6th week of the study. In addition, in terms of evaluating the effects of medical termination on the woman in the long term, a post-test will be applied at the 10th week. • After the completion of the training and evaluation in terms of ethical compliance, the support program training content and mobile application usage will be opened to the control group. Women in the control group will have access to the application after study protocol.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date July 31, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years and over, - Able to read and write, - Agreeing to participate in the study, - Accepting the decision of medical termination of pregnancy, - Does not have a diagnosed psychiatric disease, - Medical termination decision is taken in the first and second trimesters, - Women who have a phone that can use the mobile application program will be included in the study. Exclusion Criteria: - Being under the age of 18, - Those who do not agree to participate in the study, - Women who do not have a phone that can use the mobile application program will not be included in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
supportive care
After Medical Termination Navigation Assisted Care Program admission to the service will be held in the form of three interviews in the clinic before and after termination. The planned training will be given in three sessions and a different training module will be applied in each meeting. After the patient is discharged, three sessions will be held remotely via telephone.

Locations

Country Name City State
Turkey Eskisehir Osmangazi Üniversitesi Eskisehir

Sponsors (1)

Lead Sponsor Collaborator
Eskisehir Osmangazi University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary perinatal grief-1 Evaluation will be made using the scale. Change will be evaluated at the after termination(birth) using the Perinatal grief scale
Changes in the age of the patients over time will be evaluated. It will increase-decrease over time. The scale does not have any cutoff points. As the scale score increases, the level of grief increases
The termination process of the patients may vary. The perinatal grief scale is first administered in the hospital after termination.
2nd or 3rd days
Primary perinatal grief-2 Evaluation will be made using the scale. Change will be evaluated at the 7th interview (at 6-8weeks) using the Perinatal grief scale
Changes in the age of the patients over time will be evaluated. It will increase-decrease over time. The scale does not have any cutoff points. As the scale score increases, the level of grief increases
8th weeks
Primary perinatal grief-3 Evaluation will be made using the scale. Change will be evaluated at the 8th interview (at 10-12weeks) using the Perinatal grief scale
Changes in the age of the patients over time will be evaluated. It will increase-decrease over time. The scale does not have any cutoff points. As the scale score increases, the level of grief increases
12th weeks
Primary depression-anxiety-stress-1 Change will be evaluated at the after termination(birth) using the Depression Anxiety Stress Scale-21.
The depression anxiety stress scale is first interwiev in the hospital after termination. The patient is followed as long as he stays in the hospital.(avarage3-4 days) Depression anxiety stress level of the patients will be evaluated. Scale has certain cutoff points. Women's depression, anxiety and stress will be examined. Changes will be observed over time. Follow-up covers a period of 10-12 weeks. In this process, both follow-up and supportive care continue.
Depression Anxiety Stress (Respectively) NORMAL 0-4 0-3 0-7 MILD 5-6 4-5 8-9 MEDIUM LEVEL 7-10 6-7 10-12 HIGH LEVEL 11-13 8-9 13-16 VERY HIGH 4+ 10+ 17+
2nd or 3rd days
Primary depression-anxiety-stress-2 Change will be evaluated at the 7th interview (at 6-8weeks using the Depression Anxiety Stress Scale-21.
The depression anxiety stress scale is first interwiev in the hospital after termination. The patient is followed as long as he stays in the hospital.(avarage3-4 days) Depression anxiety stress level of the patients will be evaluated. Scale has certain cutoff points. Women's depression, anxiety and stress will be examined. Changes will be observed over time. Follow-up covers a period of 10-12 weeks. In this process, both follow-up and supportive care continue.
Depression Anxiety Stress (Respectively) NORMAL 0-4 0-3 0-7 MILD 5-6 4-5 8-9 MEDIUM LEVEL 7-10 6-7 10-12 HIGH LEVEL 11-13 8-9 13-16 VERY HIGH 4+ 10+ 17+
8th weeks
Primary depression-anxiety-stress-3 Change will be evaluated at the 8th interview (at 10.-12weeks) using the Depression Anxiety Stress Scale-21.
The depression anxiety stress scale is first interwiev in the hospital after termination. The patient is followed as long as she stays in the hospital.(avarage3-4 days) Depression anxiety stress level of the patients will be evaluated. Scale has certain cutoff points. Women's depression, anxiety and stress will be examined. Changes will be observed over time. Follow-up covers a period of 10-12 weeks. In this process, both follow-up and supportive care continue.
Depression Anxiety Stress (Respectively) NORMAL 0-4 0-3 0-7 MILD 5-6 4-5 8-9 MEDIUM LEVEL 7-10 6-7 10-12 HIGH LEVEL 11-13 8-9 13-16 VERY HIGH 4+ 10+ 17+
12th weeks
Primary coping and adaptation-1 Evaluation will be made using the Coping and adaptation scale.
Change will be evaluated in the hospital before termination(birth), using the Coping and Adaptation Process Scale
The increase in the coping and adjustment levels of the patients will be evaluated.
Follow-up covers a period of 10-12 weeks. In this process, both follow-up and supportive care continue.
The Coping and Adaptation process scale, on the other hand, is first applied in the hospital after the hospitalization of the patients.
first day
Primary coping and adaptation-2 Evaluation will be made using the scale. Coping and adaptation scale Change will be evaluated at the 7th interview (at 6-8weeks) using the Coping and Adaptation Process Scale
The increase in the coping and adjustment levels of the patients will be evaluated.
Follow-up covers a period of 10-12 weeks. In this process, both follow-up and supportive care continue.
8th weeks
Primary coping and adaptation-3 Evaluation will be made using the scale. Coping and adaptation scale Change will be evaluated at the 8th interview (at 10.-12weeks) using the Coping and Adaptation Process Scale
The increase in the coping and adjustment levels of the patients will be evaluated.
Follow-up covers a period of 10-12 weeks. In this process, both follow-up and supportive care continue.
12th weeks
Primary Labor Pain-1 Evaluation will be made using the VAS scale in hospital. The change in pain scores of the experimental group and the control group will be compared.
1-The latent phase covers the period until the 3-4 cm gap in labor occurs. The pain he feels during this time will be measured with a visual analog scale.
This process can take up to 1 day on average.
first day
Primary Labor Pain-2 Evaluation will be made using the VAS scale in hospital. The change in pain scores of the experimental group and the control group will be compared.
2-Pain during the act (baby's exit) will be measured with the visual analog scale.
This process can take up to 1 day on average.
first day
Primary Labor Pain-3 Evaluation will be made using the VAS scale in hospital. The change in pain scores of the experimental group and the control group will be compared.
3-The pain felt by the baby for the first two hours after the action occurs will be measured with the visual analog scale.
This process can take up to 1 day on average.
first day
Secondary discharge time The length of stay in the hospital will be calculated. Time between hospitalization and discharge. (avarage3-4 days) The time spent in the hospital can last for 3-4 days on average. Avarage 3-4 days
Secondary quality of sleeping Change will be evaluated at the 8th interview (at 10.-12weeks) using the VAS Scale.
A high score from the scale indicates good sleep quality. There are no cutoff piont on the scale.
12th weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05302505 - Simulation-based Training for Nurses and Arteriovenous Fistula Puncture in Chronic Hemodialysis Patients N/A
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Completed NCT04127097 - The Effect of Watching Cartoons During Treatment on Children's Anxiety and Fear Levels N/A
Completed NCT05057078 - The Effect of Mindfulness Program on Spiritual Well-BeingBreast Cancer Patients N/A
Completed NCT05955755 - The Effect of Butterfly Vacuum Blood Collection Set and Standard Vacutanier Needle on the Level of Pain and Fear N/A
Not yet recruiting NCT05438823 - Technology Supported Education Program Based on Human Care Theory N/A
Completed NCT05100524 - Motivational Interview for Daily Living Activities in Elderly People Undergoing Total Knee Replacement N/A
Completed NCT03645213 - Two Different Distraction Methods on Pain and Fear During Venipuncture in Children N/A
Completed NCT06053957 - The Effect of Early Mobilization on Postoperative Recovery in Abdominal Surgery N/A
Completed NCT06112600 - The Impact of Virtual Reality and Kaleidoscope in Children During Vaccination N/A
Completed NCT04676932 - Hysterosalpingography and Comfort Theory N/A
Completed NCT04961463 - Evaluation of the Psychoeducation Program Given to Behcet's Patients in the Context of the Roy Adaptation Model N/A
Completed NCT05844709 - Effectiveness of Nursing Care Bundle for the Prevention of Intraventricular Hemorrhage in Preterm Infants
Completed NCT04118322 - The Effect of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy N/A
Completed NCT05509621 - The Effect of Positions on Physiological Parameters of Preterm Neonates Receiving Mechanical Ventilation N/A
Completed NCT04827849 - Theory of Meleis on Women's Adaptation to Motherhood and Perceptions of Newborn Baby N/A
Completed NCT05877937 - Humor Therapy and Rheumatoid Arthritis N/A
Completed NCT05129839 - Use of Lightened and Musical Baby Mobile in a Pediatric Emergency Clinic N/A
Completed NCT04121247 - Nonpharmacological Approaches and Parental Education in Children With Sickle Cell Disease N/A
Completed NCT06389929 - Do the Health Education Materials Developed in the Gynecology and Diseases Nursing Course Affect Students' Teaching Material Motivation and Material Design Self-Efficacy Beliefs? N/A